Tceleron Therapeutics, Inc.
2 clinical trials · Sponsor
◉ Watch Tceleron Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| A Study of TmPSMA-02 Chimeric Antigen Receptor (CAR) T-cells in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC) (NCT05489991) | Tceleron Therapeutics, Inc. | 2022-09-06 |
| A Study of CART-PSMA-TGFβRDN in Patients With Metastatic Castration Resistant Prostate Cancer (NCT04227275) | Tceleron Therapeutics, Inc. | 2019-11-22 |
Track Tceleron Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.